Explore Roivant Sciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ROIV. Tech Stocks Surge, Steelmakers Jump On Trump's 25% Tariffs, Copper Hits 9 ...

As Big Pharma started investing in acquisitions ... in a lab coat examining a sample of blood for sickle cell diseases. Roivant Sciences Ltd. (NASDAQ:ROIV) is a biopharmaceutical company focused ...

In Roivant, Pfizer has a partner with "a proven track record in late-stage inflammation and immunology drug development," said the big pharma's chief scientific officer Mikael Dolsten. Hiving off ...

He's worth about $1 billion. So what exactly is Vivek Ramaswamy’s business background and how did he get rich so young? A quick overview.

Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...

Roivant Sciences (ROIV) announced that the members of the Board of Directors of Arbutus Biopharma (ABUS) have resigned and been replaced. As of the date hereof, Roivant beneficially owns and ...

In its fourth quarter 2024 investor letter, Tourlite Capital Management emphasized stocks such as Roivant Sciences Ltd. (NASDAQ:ROIV). Roivant Sciences Ltd. (NASDAQ:ROIV) is a commercial-stage ...

Roivant Sciences portfolio company Genevant Sciences and Canada’s Arbutus Biopharma yesterday filed five international ...

Pharmaceutical companies had more patents ... while other potential medicines would languish. In 2014, he founded Roivant Sciences to buy or license promising drugs that weren’t a priority ...